[Federal Register Volume 83, Number 245 (Friday, December 21, 2018)]
[Notices]
[Page 65695]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27737]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke, 
Interagency Pain Research Coordinating Committee Call for Committee 
Membership Nominations

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) (Department) 
has created the Interagency Pain Research Coordinating Committee 
(IPRCC) and is seeking nominations for this committee.

DATES: Nominations are due by 5 p.m. on January 25, 2019.

ADDRESSES: Nominations must be submitted through the webform on the 
IPRCC website: https://iprcc.nih.gov/About/Membership-Agency-Representation/Nomination-Form.

FOR FURTHER INFORMATION CONTACT: Linda Porter at 301-451-4460 or email 
at <a href="/cdn-cgi/l/email-protection#275748555342554b67494e49435409494e4f09404851"><span class="__cf_email__" data-cfemail="3e4e514c4a5b4c527e5057505a4d1050575610595148">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: As specified in Public Law 111-148 
(``Patient Protection and Affordable Care Act'') and amended in H.R. 6, 
(``Support for Patients and Communities Act'') the Committee will:
    (A) Develop a summary of advances in pain care research supported 
or conducted by the Federal agencies relevant to the diagnosis, 
prevention, treatment, and management of pain and diseases and 
disorders associated with pain, including information on best practices 
for the utilization of non-pharmacologic treatments, non-addictive 
medical products, and other drugs or devices approved or cleared by the 
Food and Drug Administration;
    (B) identify critical gaps in basic and clinical research on
    (i) the symptoms and causes of pain, including the identification 
of relevant biomarkers and screening models and the epidemiology of 
acute and chronic pain;
    (ii) the diagnosis, prevention, treatment, and management of acute 
and chronic pain, including with respect to non-pharmacologic 
treatments, non-addictive medical products, and other drugs or devices 
approved or cleared by the Food and Drug Administration; and
    (iii) risk factors for, and early warning signs of, substance use 
disorders in populations with acute and chronic pain;
    (C) make recommendations to the Director of NIH
    (i) to ensure that the activities of the National Institutes of 
Health and other Federal agencies are free of unnecessary duplication 
of effort;
    (ii) on how best to disseminate information on pain care and 
epidemiological data related to acute and chronic pain; and
    (iii) on how to expand partnerships between public entities and 
private entities to expand collaborative, cross-cutting research.
    Membership on the committee will include six (6) non-Federal 
members from among scientists, physicians, and other health 
professionals and six (6) non-Federal members of the general public who 
are representatives of leading research, advocacy, and service 
organizations for individuals with pain-related conditions. Members 
will serve overlapping three year terms. It is anticipated that the 
committee will meet at least once a year.
    The Department strives to ensure that the membership of HHS Federal 
advisory committees is fairly balanced in terms of points of view 
represented and the committee's function. Every effort is made to 
ensure that the views of diverse ethnic and racial groups and people 
with disabilities are represented on HHS Federal advisory committees, 
and the Department therefore, encourages nominations of qualified 
candidates from these groups. The Department also encourages geographic 
diversity in the composition of the Committee. Appointment to this 
Committee shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.
    The Department is soliciting nominations for 5 non-federal members 
from among scientists, physicians, and other health professionals and 
for 3 non-federal members of the general public who represent a leading 
research, advocacy, or service organization for people with pain-
related conditions. These candidates will be considered to fill 
positions opened through completion of current member terms. 
Nominations are due by 5 p.m. on January 25, 2019, using the IPRCC 
nomination webform: https://iprcc.nih.gov/About/Membership-Agency-Representation/Nomination-Form.

    Dated: December 11, 2018.
Walter J. Koroshetz,
Director, National Institute of Neurological Disorders and Stroke, 
National Institutes of Health.
[FR Doc. 2018-27737 Filed 12-20-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>